Design and synthesis of simple macrocycles active against vancomycin-resistant Enterococci (VRE)

被引:11
|
作者
Jia, Yanxing
Ma, Nianchun
Liu, Zuosheng
Bois-Choussy, Michele
Gonzalez-Zamora, Eduardo
Malabarba, Adriano
Brunati, Cristina
Zhu, Jieping [1 ]
机构
[1] CNRS, Inst Chim Subst Nat, F-91198 Gif Sur Yvette, France
[2] Univ Autonoma Metropolitana Iztapalapa, Mexico City 09340, DF, Mexico
[3] Vicuron Pharmaceut, Italy Res Ctr, I-21040 Gerenzano, VA, Italy
关键词
antibiotics; biaryl ether; glycopeptides; macrocycles; SNAr; vancomycin; ALA-D-LAC; GLYCOPEPTIDE ANTIBIOTICS; STRUCTURAL MODIFICATIONS; CYCLOPEPTIDE ALKALOIDS; ANTIBACTERIAL ACTIVITY; STAPHYLOCOCCUS-AUREUS; REDUCTIVE HYDROLYSIS; TEICOPLANIN AGLYCON; BINDING; DERIVATIVES;
D O I
10.1002/chem.200600137
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
16-membered meta,para-cyclophanes mimicking the vancomycin binding pocket (D-O-E ring) were designed and synthesized. The structural key features of these biaryl ether containing macrocycles are (1) the presence of P-amino-a-hydroxy acid or alpha,beta-diamino acid as the C-terminal component of the cyclopeptide and (2) the presence of a hydrophobic chain or lipidated aminoglucose at the appropriate position. Cycloetherification by an intramolecular nucleophilic aromatic substitution reaction (SNAr) is used as the key step for the construction of the macrocycle. The atropselectivity of this ring-closure reaction is found to be sensitive to the peptide backbone and chemoselective cyclization (phenol versus primary amine) is achievable. Glycosylation of phenol was realized with freshly prepared 3,4,6-tri-O-acetyl-2-N-lauroyl-2-amino-2-deoxy-alpha-D-glucopyranosyl bromide under phase-transfer conditions. Minimum inhibitory concentrations for all of the derivatives are measured by using a standard microdilution assay, and potent bioactivities against both sensitive and resistant strains are found for some of these compounds (MIC (minimum inhibitory concentration) = 4 mu g mL(-1) against VRE). From these preliminary SAR studies, it was anticipated that both the presence of a hydrophobic substituent and an appropriate structure of the macrocycle were required for this series of compounds to be active against VRE.
引用
收藏
页码:5334 / 5351
页数:18
相关论文
共 50 条
  • [31] Vancomycin-resistant enterococci
    Moellering, RC
    CLINICAL INFECTIOUS DISEASES, 1998, 26 (05) : 1196 - 1199
  • [32] Vancomycin-resistant enterococci
    Murray, BE
    AMERICAN JOURNAL OF MEDICINE, 1997, 102 (03): : 284 - 293
  • [33] Vancomycin-resistant enterococci
    Cetinkaya, Y
    Falk, P
    Mayhall, CG
    CLINICAL MICROBIOLOGY REVIEWS, 2000, 13 (04) : 686 - +
  • [34] VANCOMYCIN-RESISTANT ENTEROCOCCI
    UTTLEY, AHC
    WOODFORD, N
    JOHNSON, AP
    COOKSON, B
    GEORGE, RC
    LANCET, 1993, 342 (8871): : 615 - 615
  • [35] Vancomycin-resistant enterococci
    Roberts, RB
    JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE, 1998, 75 (03): : 512 - 513
  • [36] Vancomycin-resistant enterococci
    Gin, AS
    Zhanel, GG
    ANNALS OF PHARMACOTHERAPY, 1996, 30 (06) : 615 - 624
  • [37] Vancomycin-Resistant Enterococci
    Rubinstein, Ethan
    Keynan, Yoav
    CRITICAL CARE CLINICS, 2013, 29 (04) : 841 - +
  • [38] VANCOMYCIN-RESISTANT ENTEROCOCCI
    UTTLEY, AHC
    COLLINS, CH
    NAIDOO, J
    GEORGE, RC
    LANCET, 1988, 1 (8575-6): : 57 - 58
  • [39] VANCOMYCIN-RESISTANT ENTEROCOCCI
    RYBAK, MJ
    PALMER, SM
    PHARMACOTHERAPY, 1995, 15 (05): : 684 - 685
  • [40] Novel vancomycin dimers with activity against vancomycin-resistant enterococci
    Sundram, UN
    Griffin, JH
    Nicas, TI
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1996, 118 (51) : 13107 - 13108